Search Results - "Allen, Josiah D"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta‐analysis by Zhang, Lusi, Brown, Sarah Jane, Shan, Yuting, Lee, Adam M., Allen, Josiah D., Eum, Seenae, Leon, Jose, Bishop, Jeffrey R.

    Published in Pharmacotherapy (01-07-2020)
    “…Background Risperidone is a second‐generation antipsychotic drug metabolized to an active metabolite, 9‐hydroxyrisperidone, primarily by cytochrome P450 (CYP)…”
    Get full text
    Journal Article
  2. 2

    Assessing pharmacogenomic literacy in China through validation of the Chinese version of the Minnesota Assessment of Pharmacogenomic Literacy by Zhang, Lusi, Zhou, Shuqin, Allen, Josiah D, Wang, Fan, Pittenger, Amy L, Bishop, Jeffrey R

    Published in Clinical and translational science (01-11-2023)
    “…Pharmacogenomics (PGx) implementation into clinical care is rapidly increasing in China. However, the extent to which the public understands PGx testing and…”
    Get full text
    Journal Article
  3. 3

    Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center by Muldoon, Megan, Beck, Mollie, Sebree, Nichlas, Yoder, Robin, Ritter, Stacey, Allen, Josiah D., Alqahtani, Zuhair, Grund, Jaime, Philips, Brooke, Hesse, Kristina, El Rouby, Nihal

    Published in Clinical and translational science (01-02-2024)
    “…We set out to demonstrate the feasibility of pharmacogenetic testing of DPYD and UGT1A1 and explore the clinical benefits in a community‐based cancer center…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Intersection and Considerations for Patient-Centered Care, Patient Experience, and Medication Experience in Pharmacogenomics by Murry, Logan T, Hillman, Lisa A, Allen, Josiah D, Bishop, Jeffrey R

    Published in Pharmacy (14-09-2023)
    “…As healthcare continues to embrace the concept of person- and patient-centered care, pharmacogenomics, patient experience, and medication experience will…”
    Get full text
    Journal Article
  8. 8

    A systematic review of genome-wide association studies of antipsychotic response by Allen, Josiah D, Bishop, Jeffrey R

    Published in Pharmacogenomics (01-03-2019)
    “…Clinical symptom response to antipsychotic medications is highly variable. Genome-wide association studies (GWAS) provide a 'hypothesis-free' method of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder by Winner, Joel G, Carhart, Joseph M, Altar, C Anthony, Allen, Josiah D, Dechairo, Bryan M

    Published in Discovery medicine (01-11-2013)
    “…A prospective double-blind randomized control trial (RCT) to evaluate the benefit of a combinatorial, five gene pharmacogenomic test and interpretive report…”
    Get more information
    Journal Article
  11. 11
  12. 12

    A Scoping Review of Attitudes and Experiences with Pharmacogenomic Testing among Patients and the General Public: Implications for Patient Counseling by Allen, Josiah D, Pittenger, Amy L, Bishop, Jeffrey R

    Published in Journal of personalized medicine (09-03-2022)
    “…The use of pharmacogenomic (PGx) tests is increasing, but there are not standard approaches to counseling patients on their implications or results. To inform…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL) by Allen, Josiah D, Zhang, Lusi, Johnson, Alyssa N K, Jacobson, Pamala A, McCarty, Catherine A, Pittenger, Amy L, Bishop, Jeffrey R

    Published in Journal of personalized medicine (29-08-2022)
    “…Ensuring that patients have an adequate understanding of pharmacogenomic (PGx) test results is a critical component of implementing precision medicine into…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes by Benitez, Joachim, Jablonski, Michael R., Allen, Josiah D., Winner, Joel G.

    Published in Applied & translational genomics (01-06-2015)
    “…Prescribing safe and effective medications is a challenge in psychiatry. While clinical use of pharmacogenomic testing for individual genes has provided some…”
    Get full text
    Journal Article
  17. 17

    Population-based prevalence of smoking in psychiatric inpatients: a focus on acute suicide risk and major diagnostic groups by Lineberry, Timothy W, Allen, Josiah D, Nash, Jessica, Galardy, Christine W

    Published in Comprehensive psychiatry (01-11-2009)
    “…Abstract Objective The aim of the study was to define the extent of current and lifetime smoking by diagnostic groups and suicide risk as reason for admission…”
    Get full text
    Journal Article
  18. 18

    Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies by Altar, C Anthony, Carhart, Joseph, Allen, Josiah D, Hall-Flavin, Daniel, Winner, Joel, Dechairo, Bryan

    Published in Molecular neuropsychiatry (01-10-2015)
    “…DNA of 258 patients with treatment-resistant depression was collected in three 8-10 week, two-arm, prospective clinical trials. Forty-four allelic variations…”
    Get full text
    Journal Article
  19. 19